| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Trifluridine/tipiracil |
| Brand | Lonsurf® |
| Indication | For the treatment of adult patients with metastatic colorectal cancer who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-VEGF agents, and anti-EGFR agents. |
| Assessment Process | |
| Rapid review commissioned | 10/06/2016 |
| Rapid review completed | 11/07/2016 |
| Rapid review outcome | Full pharmacoeconomic assessment recommended at the submitted price. |